Gene · 4837
Papers1,489
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,489
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Novel biomarkers for early diagnosis involved in autoimmune and autoinflammatory diseases. | Front Immunol | 2026 | 41798923 | PubTator, text mining | PubMed |
| Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening. | Sci Rep | 2026 | 41775739 | PubTator, text mining | PubMed |
| RNA-Seq analysis reveals regulatory networks driven by EpCAM overexpression in esophageal adenocarcinoma cells. | PeerJ | 2026 | 41769390 | PubTator, text mining | PubMed |
| Plant-Derived Bioactive Compounds in Inflammation-Related Cancers: Mechanisms and Therapeutic Potential. | Plants (Basel) | 2026 | 41754282 | PubTator, text mining | PubMed |
| Molecular Signatures and Network Alterations Underlying GBM Progression and Recurrence. | Medicina (Kaunas) | 2026 | 41752735 | PubTator, text mining | PubMed |
| Metabolic Mechanisms in Electroconvulsive Therapy for Schizophrenia: Role, Potential and Future Directions. | Int J Mol Sci | 2026 | 41751887 | PubTator, text mining | PubMed |
| Thiamine transporter 2 and Janus kinase 2 inhibitor, fedratinib suppresses thermogenic activation of human neck area-derived adipocytes. | Front Endocrinol (Lausanne) | 2026 | 41743550 | PubTator, text mining | PubMed |
| Identification of Ferroptosis-Related Hub Genes and Immune Infiltration Landscape in Chronic Kidney Disease via Bioinformatics and Experimental Verification. | Immun Inflamm Dis | 2026 | 41738361 | PubTator, text mining | PubMed |
| Targeting Metabolic Vulnerabilities in Glioblastoma: a Framework for Multi-node Combination Therapy. | Curr Oncol Rep | 2026 | 41718834 | PubTator, text mining | PubMed |
| Pericyte NNMT drives an immune-hostile vascular niche and restricts cancer immunotherapy. | Sci Bull (Beijing) | 2026 | 41714234 | PubTator, text mining | PubMed |
| Proteogenomic characterization of cervical cancer identifies molecular subtypes predictive of clinical outcomes and subtype-specific targets. | J Clin Invest | 2026 | 41665935 | PubTator, text mining | PubMed |
| SIRT7 as a context-dependent biomarker and therapeutic target: Insights from a pan-cancer study. | PLoS One | 2026 | 41642899 | PubTator, text mining | PubMed |
| Time-Dependent Glucocorticoid-Induced Transcriptomic Changes in Human Trabecular Meshwork and Schlemm's Canal Cells. | Invest Ophthalmol Vis Sci | 2026 | 41636427 | PubTator, text mining | PubMed |
| The emerging role of nicotinamide N-methyltransferase in the pathogenesis and treatment of breast cancer. | Biochem Pharmacol | 2026 | 41620136 | PubTator, text mining | PubMed |
| Metastatic organotropism in peritoneal metastasis: Paget's hypothesis revisited. | Clin Exp Med | 2026 | 41609906 | PubTator, text mining | PubMed |
| Nicotinamide N-Methyl Transferase (NNMT) Sustains Innate Sensitivity to NAMPT Inhibition in YAP-dependent Stem-like/Mesenchymal Prostate Cancer. | Int J Biol Sci | 2026 | 41608637 | PubTator, text mining | PubMed |
| Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications. | Biomark Res | 2026 | 41593811 | PubTator, text mining | PubMed |
| Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma. | Sci Adv | 2026 | 41576167 | PubTator, text mining | PubMed |
| NNMT inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease. | Cell Rep | 2026 | 41543936 | PubTator, text mining | PubMed |
| GLP-1 Targeting Agents Impair Chemoimmunotherapy Effectiveness in Triple-Negative Breast Cancer. | Res Sq | 2026 | 41542041 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4837/papers?page=3